Home › GSK buys Swiss vaccine developer for $325M
 

Keywords :   


GSK buys Swiss vaccine developer for $325M

2013-05-29 18:43:57| Biotech - Topix.net

British pharma GlaxoSmithKline , which has its North American headquarters in Research Triangle Park, has acquired Swiss vaccine developer Okairos AG for about $325 million in cash.

Tags: developer swiss buys vaccine

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
03.07Hurricane Beryl Wind Speed Probabilities Number 18
03.07Hurricane Beryl Public Advisory Number 18
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 18
03.07Hurricane Beryl Graphics
More »